Once‐a‐week or every‐other‐day urethra‐sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow‐up results

BACKGROUND: To present the 18 months results from a prospective multicenter phase II randomized trial of short vs protracted urethra‐sparing stereotactic body radiotherapy (SBRT) for localized prostate cancer (PCa). METHODS: Between 2012 and 2015, a total of 170 PCa patients were randomized to 36.25...

Descripción completa

Detalles Bibliográficos
Autores principales: Zilli, Thomas, Jorcano, Sandra, Bral, Samuel, Rubio, Carmen, Bruynzeel, Anna M.E., Oliveira, Angelo, Abacioglu, Ufuk, Minn, Heikki, Symon, Zvi, Miralbell, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196054/
https://www.ncbi.nlm.nih.gov/pubmed/32160416
http://dx.doi.org/10.1002/cam4.2966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196054/
https://www.ncbi.nlm.nih.gov/pubmed/32160416
http://dx.doi.org/10.1002/cam4.2966

Ejemplares similares